EGFR/HER2 “Yale” Vaccine
Dr. Janson administers the Yale Vaccine to sweet Olive.
A new cancer immunotherapy developed by researchers at Yale University is being evaluated in this clinical trial (led by Therajan LLC). Treeline Vet is the Only USDA approved trial site in Colorado.
Treeline Vet is currently enrolling canine patients with Hemangiosarcoma, Osteosarcoma, and Urothelial Carcinoma (TCC) into the trial.
This is a USDA regulated scientific study. The EGFR/HER2 vaccine is a type of immunotherapy that directly targets the Epidermal Growth Factor Receptor (EGFR/HER2) pathway. EGFR is overexpressed in many different types of cancers, and the goal of this treatment is to induce a polyclonal anti-EGFR/HER2 tumor antigen response (or in simpler terms, to activate the immune system to help kill off cancer cells in the body).
Please contact us for more information at info@treelinevet.com or call/text 720-432-8680.
